Affiliation:
1. , Hyderabad, Telangana, India
2. , Mumbai, Maharashtra, India
Abstract
Skin and soft tissue infections (SSTIs) are common and can have serious implications.Nadifloxacin’s broad-spectrum antibiotic activity may potentially provide therapeutic benefits for skininfections. Also, it offers a viable alternative therapy for topical agent resistance.This study investigates the antimicrobial susceptibility of eight micro-organisms to four important topical antibiotics: Mupirocin, Clindamycin, Fusidic acid, and Nadifloxacin.Antibiotic susceptibility and minimum inhibitory concentration (MIC) were determined using Kirby-Bauer disk diffusion, Epsilometer test (E-Test), and Micro-broth dilution methods. Mueller Hinton and Brucella blood agar served as growth media. HiComb strips from HiMedia were used, and QC strains were tested. Kirby-Bauer assessed Zone of Inhibition; HiComb determined MIC via gradient; Micro-broth dilution gauged growth in antibiotic-diluted broth.The disk diffusion method revealed varying resistance percentages for antibiotics. Clindamycin had the highest resistance (62%) followed by fusidic acid (47%), Nadifloxacin (15%), and mupirocin (5%). Among gram-positive isolates, Nadifloxacin and mupirocin had 100% sensitivity, while Fusidic acid showed moderate resistance (19%) and clindamycin highest resistance (42%). Among gram-negative isolates, clindamycin and fusidic acid had 100% resistance, while Nadifloxacin (42%) and mupirocin (15%) showed comparatively low resistance. Among the 57 species isolates, including 49 isolates of and 8 isolates of the antibiotic susceptibility testing revealed a MIC value <4 μg/ml of Nadifloxacin, with a high level of sensitivity across all isolates. Nadifloxacin’s superior efficacy in the study can be attributed to its mechanism of action, targeting bacterial DNA gyrase and topoisomerase IV, making it suitable for bacterial infections, particularly those involving the skin and soft tissuesOut of four antibiotics tested, Nadifloxacin was found to be effective against both gram-positive and gram-negative strains of bacteria.
Publisher
IP Innovative Publication Pvt Ltd
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference25 articles.
1. Ramakrishnan K, Salinas RC, Higuita NI, Skin and soft tissue infections..Am Fam Physician. 2015;92(6):474-83
2. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America..Clin infect Dis 2014;59(2):10-52
3. Muchhala S, Sarkar R, Lahiri K, Kharkar RD, Rathod R, Management of skin and soft-tissue infections and acne with topical Nadifloxacin: a comprehensive review.Int J Res 2022;8(6):551
4. Sarkar R, Tahiliani S, Madan A, Abraham A, Ganjoo A, Shah BJ, Role of topical Nadifloxacin as an empirical treatment in patients with skin and soft-tissue infections in India: A review and consensus.. Cosmoderma 2021;1(61):1-13
5. Krishna S, Hegde SP, Shenoy MM, Topical antibacterials: Current concepts and advances.BLDE Univ J Health Sci 2020;5(1):1-3